|
Use of current literature
|
Current literature, updated every 3–18 months
|
Mostly current, some historical information
|
|
Starting assumptions/appearance of impartiality
|
|
Appears to give favorable consideration toward the approved German Commission E monographs (the basis for about half of the monographs) as “approved by the Commission E,” without critical evaluation
|
|
Use of peer review
|
Introductory information describes an evidencedbased, consensus-based, peer review
|
No indication of peer review found
|
|
Focus on a particular standardized product and discussion of preparation impact on safety
|
Does not appear to focus on specific preparations
|
A number of different preparations are described, impact on safety is described for some; for monographs based on conclusions of Commission E, usefulness of conclusions depends on similarities of German products to products consumed in the United States
|
|
Description of consumption levels considered
|
A recommended use amount is described; it is assumed that safety conclusions are based on this amount
|
Recommended doses are described
|
|
Consideration of data from non-oral routes of exposure
|
No mention is made of how non-oral data were handled in the example reviewed
|
No mention is made of how non-oral data were handled
|
|
Discussion of biological activity or possible mechanism of action
|
Discussed
|
Addressed, but not necessarily with safety in mind
|
|
Discussion of specific groups within the general population, if appropriate
|
Pregnant and lactating women are addressed
|
Second edition has separate indexes for herbs not for use during pregnancy or lactation or for use only under supervision
|
|
Interaction with other interventions
|
Thorough section on interactions with conventional therapies, drugs, other herbs, and supplements
|
Interactions discussed and a Drug/Herb Interaction Guide is included
|